简 EN 繁
简 EN 繁

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
News Center News Center

News Center

2025.12.10

​Shanghai Bao Pharma Successfully Listed on the Hong Kong Stock Exchange, Ushering in a New Era of Recombinant Biologics

View details
​Shanghai Bao Pharma Successfully Listed on the Hong Kong Stock Exchange, Ushering in a New Era of Recombinant Biologics
Bao Pharma’s Recombinant Ulinastatin (BJ044) IND Accepted, Marking a New Era for Recombinant Protein Therapeutics
2026.04.17

Bao Pharma’s Recombinant Ulinastatin (BJ044) IND Accepted, Marking a New Era for Recombinant Protein Therapeutics

View details
Recombinant Human Hyaluronidase for Injection Approved for Market — A Classic Enzyme Opening a New Era of Subcutaneous Infusion
2026.04.08

Recombinant Human Hyaluronidase for Injection Approved for Market — A Classic Enzyme Opening a New Era of Subcutaneous Infusion

View details
Initiation of KJ103 Phase III Clinical Trial China's Innovative Drug Opens a New Era for Anti-GBM Disease Treatment
2025.12.28

Initiation of KJ103 Phase III Clinical Trial China's Innovative Drug Opens a New Era for Anti-GBM Disease Treatment

View details
Pharma News | How Bao Pharma Demonstrates Differentiated Breakthrough
2025.12.26

Pharma News | How Bao Pharma Demonstrates Differentiated Breakthrough

View details
1234